Related Experiment Video
Updated: Jan 28, 2026

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
Published on: July 25, 2017
Fructooligosaccharides Ameliorating Cognitive Deficits and Neurodegeneration in APP/PS1 Transgenic Mice through
Jing Sun1, Suzhi Liu2, Zongxin Ling3
1Department of Neurology , the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University , Wenzhou , Zhejiang 325027 , China.
Abstract:
Alzheimer's disease (AD) is closely related to gut microbial alteration. Prebiotic fructooligosaccharides (FOS) play major roles by regulating gut microbiota. The present study aimed to explore the effect and mechanism of FOS protection against AD via regulating gut microbiota. Male Apse/PSEN 1dE9 (APP/PS1) transgenic (Tg) mice were administrated with FOS for 6 weeks. Cognitive deficits and amyloid deposition were evaluated. The levels of synaptic plasticity markers including postsynaptic density protein 95 (PSD-95) and synapsin I, as well as phosphorylation of c-Jun N-terminal kinase (JNK), were determined. The intestinal microbial constituent was detected by 16S rRNA sequencing. Moreover, the levels of glucagon-like peptide-1 (GLP-1) in the gut and GLP-1 receptor (GLP-1R) in the brain were measured. The results indicated that FOS treatment ameliorated cognitive deficits and pathological changes in the Tg mice. FOS significantly upregulated the expression levels of synapsin I and PSD-95, as well as decreased phosphorylated level of JNK. The sequencing results showed that FOS reversed the altered microbial composition. Furthermore, FOS increased the level of GLP-1 and decreased the level of GLP-1R in the Tg mice. These findings indicated that FOS exerted beneficial effects against AD via regulating the gut microbiota-GLP-1/GLP-1R pathway.
Insights
Prebiotic fructooligosaccharides (FOS) improve cognition and reduce Alzheimer's disease pathology by modulating gut bacteria and the gut microbiota-GLP-1/GLP-1R pathway.
Area of Science:
- Neuroscience
- Microbiology
- Pharmacology
Background:
- Alzheimer's disease (AD) is linked to changes in gut microbiota.
- Prebiotics like fructooligosaccharides (FOS) can regulate gut bacteria.
- Understanding FOS's protective mechanisms against AD is crucial.
Purpose of the Study:
- To investigate the protective effects of FOS against Alzheimer's disease (AD) in a mouse model.
- To explore the underlying mechanisms involving gut microbiota modulation and the GLP-1/GLP-1R pathway.
Main Methods:
- Administered FOS to male APP/PS1 transgenic mice for 6 weeks.
- Assessed cognitive function, amyloid deposition, synaptic plasticity markers (PSD-95, synapsin I), and JNK phosphorylation.
- Analyzed gut microbial composition using 16S rRNA sequencing.
- Measured gut glucagon-like peptide-1 (GLP-1) and brain GLP-1 receptor (GLP-1R) levels.
Main Results:
- FOS treatment improved cognitive deficits and reduced amyloid pathology in transgenic mice.
- FOS upregulated synaptic plasticity markers (synapsin I, PSD-95) and decreased JNK phosphorylation.
- FOS altered gut microbial composition towards a healthier state.
- FOS increased GLP-1 levels in the gut and affected GLP-1R levels in the brain.
Conclusions:
- Fructooligosaccharides (FOS) demonstrate beneficial effects in an Alzheimer's disease mouse model.
- FOS exerts neuroprotection by regulating gut microbiota composition.
- The gut microbiota-GLP-1/GLP-1R signaling pathway is a key mechanism for FOS's therapeutic action in AD.
Related Concept Videos
Transgenic Organisms
Cognitive Dissonance
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Transgenic Plants
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
Language and Cognition
Cognitive Therapy

